Changes

no edit summary
Line 2,225: Line 2,225:  
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
|'''''Medulloblastoma, WNT-activated'''''||'''''Disease'''''||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
+
|Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 
|9/20/21
 
|9/20/21
 
|
 
|
 
|PENDING
 
|PENDING
 +
|
 +
|
 +
|
 +
|2021 template added
 +
|-
 +
|Paediatric-type diffuse high-grade gliomas
 +
|Overview
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|2021 template added
 +
|-
 +
|Diffuse midline glioma, H3 K27-altered
 +
|Disease
 +
|Laveniya Satgunaseelan
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|2021 template added
 +
|-
 +
|Diffuse hemispheric glioma, H3 G34-mutant
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|2021 template added
 +
|-
 +
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|2021 template added
 +
|-
 +
|Infant-type hemispheric glioma
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|